|
1 |
Praxisfeld Klinische Ethik
Woellert, Katharina. - Berlin : Medizinisch Wissenschaftliche Verlagsgesellschaft, [2021]
|
|
|
2 |
Cabozantinib and Tivantinib, but Not INC280, Induce Antiproliferative and Antimigratory Effects in Human Neuroendocrine Tumor Cells in vitro: Evidence for 'Off-Target' Effects Not Mediated by c-Met Inhibition
Reuther, Clemens. - Ludwig-Maximilians-Universität München, 2016
|
|
|
|
3 |
Endokrine Tumoren
Germering/München : Zuckschwerdt, 2013, 3., überarb. Aufl.
|
|
|
|
4 |
Endokrine Tumoren
Germering bei München : W. Zuckschwerdt Verlag, 2013, 3. Auflage
|
|
|
|
5 |
Loss of TRAIL-receptors is a recurrent feature in pancreatic cancer and determines the prognosis of patients with no nodal metastasis after surgery.
Gallmeier, Eike. - Ludwig-Maximilians-Universität München, 2013
|
|
|
|
6 |
Microsatellite instability, KRAS mutations and cellular distribution of TRAIL-receptors in early stage colorectal cancer.
Kriegl, Lydia. - Ludwig-Maximilians-Universität München, 2012
|
|
|
|
7 |
JNK inhibition sensitises hepatocellular carcinoma cells but not normal hepatocytes to the TNF-related apoptosis-inducing ligand.
Mucha, Simon R.. - Ludwig-Maximilians-Universität München, 2009
|
|
|
|
8 |
Endokrine Tumoren
München [i.e.] Germering : Zuckschwerdt, 2008, 2. Aufl.
|
|
|
|
9 |
Gastroenterologie systematisch
Bremen : UNI-MED, 2007, 2. Aufl.
|
|
|
|
10 |
Endokrine Tumoren
München [i.e.] Germering : Zuckschwerdt, 2006, 1. Aufl.
|
|
Administration
